Login
$MRK
$144.82 +$0.36 (0.25%) After hours

$MRK 8-K/A SEC Filings

Filed On Filing
01 Feb 2019 8-K/A: Financial Statements and Exhibits

Sum of quarterly amounts may not equal year-to-date amounts due to rounding.

12 Oct 2011 8-K/A: Submission of Matters to a Vote of Security Holders

In accordance with the Board of Directors’ recommendation, and based on the results of the vote reported under Item 5.07 of the Original Report, the Company will hold an annual non-binding advisory vote on the compensation of the named e...

18 Nov 2009 8-K/A: Financial Statements and Exhibits

On November 3, 2009, Merck & Co., Inc. and Schering-Plough Corporation (“Schering-Plough”) combined in a stock and cash transaction. The transaction was structured as a “reverse merger” in which Schering-Plough, renamed Merck, continued ...

21 Jul 2008 8-K/A: Financial Statements and Exhibits

The University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) proposed that the hypothesis-generating results of the SEAS trial of ezetimibe should be tested by reviewing the combined cancer results from th...

28 Jan 2008 8-K/A: Regulation FD Disclosure

From time to time, Investor Relations will provide FAQs on various topics of interest. The following is a compilation of recent FAQs related to the ENHANCE trial and other items.

22 Jan 2008 8-K/A: Financial Statements and Exhibits

The following unaudited pro forma condensed combined balance sheet and unaudited pro forma condensed statements of combined operations as of and for the nine months ended September 30, 2007 and for the year ended December 31, 2006 have b...

22 Apr 2005 8-K/A: Results of Operations and Financial Condition; Other Events

FOR RELEASE: IMMEDIATELY Media Contact: Steve Galpin, Jr. (908) 298-7415 Investor Contacts: Alex Kelly Janet M. Barth (908) 298-7436

22 Aug 2003 8-K/A: Other Events
13 Aug 2003 8-K/A: Regulation FD Disclosure

From time to time, Investor Relations will provide FAQs on various topics of interest to investors. The following is a compilation of frequently asked questions.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support